Treatment patterns and long-term outcomes in anti-VEGF-treated macular oedema secondary to retinal vein occlusion: a retrospective observational study

Christiana Dinah; Melanie Dodds; Andrew Lotery; Serena Salvatore; Emily Fletcher; Alice V. R. Lake; Antony Parker; Liliana Pereira; Anne-Cecile Retiere; Insaf Saffar; Pablo Arrisi; Indra Dias; R J Antcliff; Faruque Ghanchi; James Talks; C Brand; Aires Lobo; Louise Downey; Colin Jones; Sheena George; Ashish Patwardhan; Yinka Osoba; Balasubramanian Ramasamy; C. Gloria

doi:10.1038/s41433-025-04089-2

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

VA improvements were observed soon after anti-VEGF treatment, but were lower with longer follow-up through 60 months, alongside lower annual injection numbers, suggesting that current single-target intravitreal anti-VEGFs may not be sufficiently durable for long-term RVO management in routine practice.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dinah et al. (2025) studied this question.

synapsesocial.com/papers/69de7b29726bee048db0c3de https://doi.org/10.1038/s41433-025-04089-2

View Full Paper

Ask AI

Bookmark

Share

Treatment patterns and long-term outcomes in anti-VEGF-treated macular oedema secondary to retinal vein occlusion: a retrospective observational study

Ask about this paper

Abstract

Discussion

Cite This Study

Treatment patterns and long-term outcomes in anti-VEGF-treated macular oedema secondary to retinal vein occlusion: a retrospective observational study

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading